143 related articles for article (PubMed ID: 2842508)
21. Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39.
Huang WM
Nucleic Acids Res; 1986 Oct; 14(19):7751-65. PubMed ID: 3022233
[TBL] [Abstract][Full Text] [Related]
22. A bacteriophage model system for studying topoisomerase inhibitors.
Kreuzer KN
Adv Pharmacol; 1994; 29B():171-86. PubMed ID: 8996607
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors.
Freudenreich CH; Kreuzer KN
EMBO J; 1993 May; 12(5):2085-97. PubMed ID: 8387918
[TBL] [Abstract][Full Text] [Related]
24. T4 DNA topoisomerase: a new ATP-dependent enzyme essential for initiation of T4 bacteriophage DNA replication.
Liu LF; Liu CC; Alberts BM
Nature; 1979 Oct; 281(5731):456-61. PubMed ID: 226889
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase II and other DNA-delay and DNA-arrest mutations impair bacteriophage T4 DNA packaging in vivo and in vitro.
Zachary A; Black LW
J Virol; 1986 Oct; 60(1):97-104. PubMed ID: 3018302
[TBL] [Abstract][Full Text] [Related]
26. A Review on Acridines as Antiproliferative Agents.
Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
[TBL] [Abstract][Full Text] [Related]
27. Ligase-defective bacteriophage T4. I. Effects on mutation rates.
Koch RE; Drake JW
J Virol; 1973 Jan; 11(1):35-40. PubMed ID: 4567687
[TBL] [Abstract][Full Text] [Related]
28. Mutator versus antimutator activity of a T4 DNA polymerase mutant distinguishes two different frameshifting mechanisms.
Ripley LS; Glickman BW; Shoemaker NB
Mol Gen Genet; 1983; 189(1):113-7. PubMed ID: 6574304
[TBL] [Abstract][Full Text] [Related]
29. Relationship between bacteriophage T4 and T6 DNA topoisomerases. T6 39-protein subunit is equivalent to the combined T4 39- and 60-protein subunits.
Huang WM; Wei LS; Casjens S
J Biol Chem; 1985 Jul; 260(15):8973-7. PubMed ID: 2991231
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity.
Goodell JR; Madhok AA; Hiasa H; Ferguson DM
Bioorg Med Chem; 2006 Aug; 14(16):5467-80. PubMed ID: 16713270
[TBL] [Abstract][Full Text] [Related]
31. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
Liu LF; Liu CC; Alberts BM
Cell; 1980 Mar; 19(3):697-707. PubMed ID: 6244895
[TBL] [Abstract][Full Text] [Related]
32. In vivo restriction. Sequence and structure of endonuclease II-dependent cleavage sites in bacteriophage T4 DNA.
Krabbe M; Carlson K
J Biol Chem; 1991 Dec; 266(34):23407-15. PubMed ID: 1744134
[TBL] [Abstract][Full Text] [Related]
33. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
[TBL] [Abstract][Full Text] [Related]
34. 9-Aminoacridine mutagenesis of bacteriophage T4 intracellular DNA.
Altman S; Warner V
Mol Gen Genet; 1975 Jul; 138(4):333-43. PubMed ID: 1152842
[TBL] [Abstract][Full Text] [Related]
35. Frameshift mutagenesis in bacteriophage T7.
Pierce JC; Masker W
Mutat Res; 1992 Feb; 281(2):81-7. PubMed ID: 1370985
[TBL] [Abstract][Full Text] [Related]
36. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
O'Reilly EK; Kreuzer KN
Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589
[TBL] [Abstract][Full Text] [Related]
37. Frameshift mutagenesis of lambda prophage by 9-aminoacridine, proflavin and ICR-191.
Skopek TR; Hutchinson F
Mol Gen Genet; 1984; 195(3):418-23. PubMed ID: 6236349
[TBL] [Abstract][Full Text] [Related]
38. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
[TBL] [Abstract][Full Text] [Related]
39. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
[TBL] [Abstract][Full Text] [Related]
40. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
